Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Asthma: Pathogenesis and Management

Asthma: Pathogenesis and Management

Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.

Asthma-IV: Diagnostic and Management

Asthma-IV: Diagnostic and Management

The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs

Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...

Asthma-II: Pathophysiology and Classification

Asthma-II: Pathophysiology and Classification

Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:

Asthma-I: Introduction

Asthma-I: Introduction

Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...

Asthma I: Introduction

Asthma I: Introduction

Asthma is a chronic inflammatory disorder of the airways characterized by variable airflow obstruction and heightened bronchial responsiveness to a wide range of triggers. The underlying inflammation leads to airway swelling, mucus hypersecretion, and smooth muscle constriction, all of which narrow the airway lumen and impede airflow. Clinically, asthma presents with recurrent episodes of wheezing, shortness of breath, chest tightness, and coughing, symptoms that typically vary in intensity and...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Pathological gamma oscillations, impaired dopamine release, synapse loss and reduced dynamic range of unitary glutamatergic synaptic transmission in the striatum of hypokinetic Q175 Huntington mice.

Neuroscience·2015

Same author

[Lung function testing in private practice].

Praxis·2012

Same author

[COPD and Asthma: same same but different].

Praxis·2012

Same author

Rat retinal benzodiazepine receptors are controlled by visual cortical mechanisms.

Neurochemistry international·2010

Same author

[COPD--Update 2009].

Praxis·2009

Same author

[Trial end-point in chronic obstructive pulmonary disease (COPD): minimal clinically important difference].

Pneumologie (Stuttgart, Germany)·2008

Search research articles

Related Experiment Video

Updated: May 14, 2026

Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma

Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma

Published on: November 4, 2010

[Asthma phenotypes and phenotyp-specific treatment].

¹Innere Medizin & Pneumologie, Zürcher Höhenklinik Davos, Klinikstrasse 6, 7272 Davos Clavadel. thomas.rothe@zhd.ch

|February 13, 2013

Summary

Asthma presents with varied phenotypes, not a single entity. Identifying individual asthma phenotypes is crucial for effective treatment, including allergen immunotherapy for allergic asthma.

Area of Science:

Pulmonology
Immunology
Allergy

Context:

Asthma is a complex respiratory condition characterized by bronchial inflammation and airway hyperresponsiveness.
Current asthma management often involves topical steroids and long-acting beta-agonists.
Recognizing distinct asthma phenotypes is key to optimizing patient care.

Purpose:

To highlight the heterogeneity of asthma beyond common symptoms.
To emphasize the role of phenotype identification in guiding therapeutic strategies.
To underscore the importance of diagnostic workup for persistent asthma.

Summary:

Asthma is a heterogeneous disease with multiple phenotypes, not a single homogenous condition.
Phenotype-specific treatments, such as allergen immunotherapy for allergic asthma, offer new therapeutic avenues.

More Related Videos

Murine Model of Allergen Induced Asthma

Murine Model of Allergen Induced Asthma

Published on: May 14, 2012

Related Experiment Videos

Last Updated: May 14, 2026

Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma

Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma

Published on: November 4, 2010

Murine Model of Allergen Induced Asthma

Murine Model of Allergen Induced Asthma

Published on: May 14, 2012

A thorough diagnostic evaluation is essential for identifying individual asthma phenotypes, especially when asthma control is suboptimal.

Impact:

Improved asthma management through personalized treatment approaches.
Enhanced understanding of asthma pathophysiology and its clinical manifestations.
Potential for better patient outcomes by tailoring therapies to specific asthma phenotypes.